Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Trump's tariffs are expected to affect the pharmaceutical industry by leading to higher costs and lower margins for companies like J&J, AstraZeneca, Novo Nordisk, and Roche. This could result in financial setbacks for these companies. Meanwhile, GH's inhaled psychedelic has shown success in treating depression, which could provide a new treatment option for patients. In other news, Pfizer's Braftovi has shown promising results in a phase III trial for colorectal cancer, AbbVie's marketing misstep has impacted its aesthetics sales, and Takeda has dropped an epilepsy drug while appointing a new CEO. Overall, the pharmaceutical industry is experiencing various developments and challenges that could impact its future.